1-866-647-3279

18

Nov 2022

Gaize releases ocular cannabis impairment testing device
November 18, 2022 By
A novel cannabis intoxication testing device developed by Montana tech company Gaize, Inc. detected irregular eye movement in hundreds of subjects who consumed cannabis in a recent clinical trial. On […] Read More >>

18

Nov 2022

Detecting Active Cannabis Impairment From Eye Movement? Gaize Completes Clinical Trial
November 18, 2022 By
dicentra, a leading Contract Research Organization (CRO) and global consulting firm is proud to congratulate their client, Gaize, Inc. as they announced completion of the world’s largest clinical trial investigating cannabis […] Read More >>

14

Nov 2022

FDA Concludes that Nicotinamide Mononucleotide (NMN) Cannot be Marketed or Sold in Dietary Supplements
FDA Concludes that Nicotinamide Mononucleotide (NMN) Cannot be Marketed or Sold in Dietary Supplements
By
The FDA recently published responses to several new dietary ingredient notifications (NDIN) submitted for nicotinamide mononucleotide (most notably the November 8, 2022 response to Inner Mongolia Kingdomway Pharmaceutical Ltd. “Kingdomway”). […] Read More >>
dicentra Appoints New Chief Financial Officer, Alka Sood
November 10, 2022 By
dicentra, a leading Contract Research Organization (CRO) and Global Consulting firm, is pleased to announce the appointment of veteran financial executive Alka Sood as the new Chief Financial Officer (CFO), […] Read More >>
dicentra’s Hala Mousa Joins the Board of Directors for the Natural Health Product Research Society of Canada (NHPRS)
November 9, 2022 By
dicentra, a leading Contract Research Organization (CRO) and global consulting firm for the life sciences and food industries, is pleased to announce that Hala Mousa, a Regulatory Affairs Manager at […] Read More >>

03

Nov 2022

Monkeypox Testing – U.S Pathways to Licensing
Monkeypox Testing – U.S Pathways to Licensing
By
Monkeypox, the disease caused by the animal-to-human transmission of the Monkeypox virus, is a zoonosis of the Orthopoxvirus genus within the Poxviridae family. Usually endemic to regions of central and […] Read More >>
AllerPops wraps up clinical trials of its allergy relief lollipops
November 1, 2022 By
dicentra, a leading Contract Research Organization (CRO) and global consulting firm is proud to congratulate their client, Allerpops who just wrapped up clinical trials of its flagship product — lollipops […] Read More >>

25

Oct 2022

GRAS, New Dietary Ingredients (NDI’s), Old Dietary Ingredients (ODI’s), and Food Additives – Is Your Product Classified Correctly?
GRAS, New Dietary Ingredients (NDI’s), Old Dietary Ingredients (ODI’s), and Food Additives – Is Your Product Classified Correctly?
By
To be used in foods and dietary supplements, ingredients must: be determined to be Generally Recognized as Safe (GRAS), be approved as a New Dietary Ingredient (NDI), be considered an […] Read More >>

21

Oct 2022

What is the Difference Between a DIN and an NPN?
What is the Difference Between a DIN and an NPN?
By
Bringing a drug or a natural health product to market in Canada involves applying for an 8-digit numerical code, called a DIN for drugs, or an NPN for natural health […] Read More >>
AllerPops Completes Enrolment in Phase II Clinical Trial; Results Expected by October 21st, 2022
September 27, 2022 By
dicentra, a world-renowned Contract Research Organization (CRO) and global consulting firm is proud to congratulate their client, Allerpops, who has completed enrolment on their phase II clinical trial on allergic […] Read More >>

22

Sep 2022

Monkeypox Testing – Canadian Pathways to Licensing
Monkeypox Testing – Canadian Pathways to Licensing
By
Monkeypox, the disease caused by the animal-to-human transmission of the Monkeypox virus, is a zoonosis of the Orthopoxvirus genus within the Poxviridae family. While appearing similar to smallpox, it is […] Read More >>
Calling for Volunteers: Gaize and dicentra Open Participant Enrolment for VR Cannabis Impairment Clinical Trial
September 20, 2022 By
dicentra, a world-renowned Contract Research Organization (CRO) and global consulting firm, is pleased to announce that it has opened participant enrolment for a new groundbreaking cannabis impairment study with its […] Read More >>

26

Jul 2022

Health Canada Introduces New Regulatory Framework for the Sale of Supplemented Foods
Health Canada Introduces New Regulatory Framework for the Sale of Supplemented Foods
By
On July 20, 2022, Health Canada published amendments to the Food and Drug Regulations (FDR), introducing new regulations for supplemented foods as a category. These new regulations continue to protect […] Read More >>

26

Jul 2022

Changes to Natural Health Product Regulations (NHPR) Labelling Requirements
Changes to Natural Health Product Regulations (NHPR) Labelling Requirements
By
New labelling requirements announced by Health Canada in Canada Gazette, Part II, Volume 156, Number 14 titled “Regulations Amending the Natural Health Products Regulations” have come into effect as of […] Read More >>

12

Jul 2022

How Much Does it Cost to Get an MDEL & MDL Approval?
How Much Does it Cost to Get an MDEL & MDL Approval?
By
The cost to obtain an MDEL (Medical Device Establishment Licence) and MDL (Medical Device Licence) in Canada depends on the medical device’s classification. In this blog, we will break down […] Read More >>

05

Jul 2022

What is Bioanalytical Testing?
What is Bioanalytical Testing?
By
Bioanalysis is the quantitative evaluation of analytes/substances in biological matrices such as tissue, blood, serum, urine, or other body fluids. Bioanalytical testing involves using a validated bioanalytical method for the […] Read More >>
The Global Regulatory Affairs Outsourcing Market is expected to grow at a CAGR of 12.73%
June 30, 2022 By
The following factors will drive the global regulatory affairs outsourcing market growth during the forecast period: Increasing Use of Digital Platforms/Solutions in Regulatory Affairs.Changing Regulatory Landscape.Rising Demand For Fast Drug […] Read More >>
dicentra Helps NNB Nutrition Achieve Self-Affirmed GRAS (Generally Recognized as Safe) Status for Its Antioxidant MitoPrime® And Exercise Factor MitoBurn®
June 23, 2022 By
Leading contract research organization and professional consulting firm dicentra is proud to announce that their valued client, NNB Nutrition, has successfully achieved self-affirmed GRAS (Generally Recognized as Safe) status for […] Read More >>

15

Jun 2022

How Much Does it Cost to Get a 510(K) Approval?
How Much Does it Cost to Get a 510(K) Approval?
By
This blog is meant to be an overview of the average costs associated with bringing a medical device to market under normal circumstances. Depending on when you are reading this […] Read More >>

31

May 2022

ALERT: New European Union In Vitro Diagnostics Regulations (EU IVDR) to replace In Vitro Diagnostic Medical Devices Directive (98/79/EC)
ALERT: New European Union In Vitro Diagnostics Regulations (EU IVDR) to replace In Vitro Diagnostic Medical Devices Directive (98/79/EC)
By
The new European Union In Vitro Diagnostics Regulations (EU IVDR) entered into application on May 26, 2022, to replace In Vitro Diagnostic Medical Devices Directive (98/79/EC). Manufacturers, authorized representatives, importers, and […] Read More >>

    Menu
    Online Learning
    Subscribe

    Stay up to date on regulatory and compliance updates, news, and events!

      © dicentra. All Rights Reserved.
      Privacy Statement | Terms & Conditions